- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04742244
Lemon Verbena Extract Oxidative Stress and Muscle Damage
March 8, 2021 updated by: Chi-Chang Huang, National Taiwan Sport University
Evaluation of the Efficacy of Supplementation With Lemon Verbena Extract in Improving
In the present study, investigators investigated whether supplementation with lemon verbena extract (LVE) could improve muscle damage and biochemical indicators after exhaustive exercise challenge.
Based on maximum jump heights, 60 subjects (30 males and 30 females) were equally divided into a placebo group (0 mg/human/day) and an LVE supplement group (400 mg/human/day), with gender-equal distribution.
All subjects started supplementation 10 days before exhaustive exercise and continued it until all tests were completed.
Before the intervention, after the exhaustive exercise, and on the following 3 days, the participants underwent 12-minute Cooper running/walking; blood collection; assessments of pain, muscle stiffness, maximum jump heights, and isometric maximum muscle strength; and anaerobic strength tests.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- National Taiwan Sport University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 30 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- health
- Must be able to swallow tablets
Exclusion Criteria:
- non-smokers
- no musculoskeletal
- medical
- metabolic disease
- women not on the reproductive cycle
- high blood pressure, asthma
- skeletal neuromuscular injuries in the upper or lower extremities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Placebo
0 mg LVE/capsule, 2capsule/day, 14days
|
Each capsule contained 0 mg of lemon verbena extract 2 capsules/day, 14 days
|
EXPERIMENTAL: Lemon Verbena extract
200 mg LVE/capsule, 2capsule/day, 14days
|
Each capsule contained 200 mg of lemon verbena extract 2 capsules/day, 14 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
inflammation of IL-6 level
Time Frame: 10 days
|
To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises.
At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters.
Assess serum IL-6 levels (pg/ml) to monitor physiological fitness.
Used commercial kit human IL-6 immunoassay (R&D system, Minnesota, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis
|
10 days
|
Clinical Biochemistry of CK level
Time Frame: 10 days
|
To assess muscle damage, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises.
At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters.
Serum CK (U/L), were assessed for monitoring physiological adaptation.
All biochemical indices were assessed using an autoanalyzer (Hitachi 7060, Tokyo, Japan).
|
10 days
|
Stress hormones 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) in Urine
Time Frame: 10 days
|
Subjects' urine was collected 24 hours after the exhaustive exercise for analysis.
Used commercial kit human 8-OHdG (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis
|
10 days
|
Assessment of muscle stiffness
Time Frame: 10 days
|
3 h, 24h, 48h after exhausting exercise, use Myoton machine to evaluate muscle stiffness (N/m) (Myoton, Tallinn, Estonia)
|
10 days
|
Visual Analogue Scale (VAS) evaluation
Time Frame: 10 days
|
3 h, 24h, 48h after exhausting exercise, use VAS questionnaire to record muscle pain.
the minimum is 0 and maximum is 10, and whether higher scores mean more pain
|
10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chi-Chang Huang, Ph.D, PI
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 28, 2020
Primary Completion (ACTUAL)
July 28, 2020
Study Completion (ACTUAL)
August 13, 2020
Study Registration Dates
First Submitted
January 25, 2021
First Submitted That Met QC Criteria
February 2, 2021
First Posted (ACTUAL)
February 8, 2021
Study Record Updates
Last Update Posted (ACTUAL)
March 10, 2021
Last Update Submitted That Met QC Criteria
March 8, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Soreness
-
Indiana UniversityRecruitingDelayed Onset Muscle SorenessUnited States
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedDelayed-onset Muscle SorenessTaiwan
-
NewChapter, Inc.Procter and GambleCompletedDelayed Onset Muscle SorenessUnited States
-
Lotus Clinical Research, LLCNovartis PharmaceuticalsCompletedPain | Delayed Onset Muscle SorenessUnited States
-
Prof. Dr. med. Frank Christoph MoorenUniversity of Giessen; Biologische Heilmittel Heel GmbHCompletedExercise-induced Muscle SorenessGermany
-
Canopy Growth CorporationCompletedDelayed Onset Muscle Soreness (DOMS)United States
-
Bradley UniversityCompletedDelayed Onset Muscle SorenessUnited States
-
Riphah International UniversityCompletedEffects of Percussive Massage Treatment With Theragun on Post Exercise Delayed Onset Muscle SorenessDelayed Onset Muscle SorenessPakistan
-
Catherine MikusCompleted
-
Aponia Laboratories, Inc.CompletedPain | Delayed Onset Muscle SorenessUnited States
Clinical Trials on maltodextrin
-
Northwestern UniversityUniversity of Illinois at ChicagoActive, not recruitingParkinson Disease | Dietary Modification | Intestinal Bacteria Flora DisturbanceUnited States
-
University of BathUniversity of BirminghamCompleted
-
NestléCompleted
-
University of FoggiaCasa Sollievo della Sofferenza IRCCSActive, not recruitingCesarean Section ComplicationsItaly
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingHIV | Breast Feeding | Infant MorbiditySouth Africa
-
Biofortis, Merieux NutriSciencesLonza Inc.CompletedGut MicrobiotaUnited States
-
SyralBiofortis Mérieux NutriSciences; CreaBio Rhone-AlpesCompletedHealthy | Functional ConstipationFrance
-
Nanjing PLA General HospitalCompletedIrritable Bowel Syndrome
-
NestléCompletedSeasonal Allergic RhinitisSwitzerland
-
NestléCompletedCeliac Disease | Non-celiac Gluten SensitivityNetherlands